“Letter to the Editor Regarding the Article ‘Use of Autologous Dendritic Cell Vaccine CaTeVac in Melanoma Patients: Final Results of the DENDRON-01 Study’” (2026) Voprosy onkologii, 72(1), p. OF-2542. doi:10.37469/0507-3758-2026-72-1-OF-2542.